Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cencora

COR Clue Score59
United States Fiscal year ends September CIK 0001140859 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert P. Mauch
20 Feb 2026
President & CEO
Sold after exercise
3,762
$358.94
$1.35M
Robert P. Mauch
20 Jan 2026
President & CEO
Sold after exercise
5,096
$354.73
$1.81M
Robert P. Mauch
18 Dec 2025
President & CEO
Sold after exercise
5,096
$343.45
$1.75M
Robert P. Mauch
18 Nov 2025
President & CEO
Sold after exercise
5,096
$366.64
$1.87M

What was left out

Form 4 filings counted 69
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 369,833
History held since 2 Nov 2006